GlassScriptPhysician profile
Dana Lavian
NPI 1720010200
$3,494.03
in general payments reported to CMS, 2019-2025
35 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $261 · 2021: $287 · 2022: $355 · 2023: $362 · 2024: $548 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $890.68 | 2019-2022 | |
| Smith+Nephew, INC. | $538.81 | 2019-2025 | Grafix Pl, Stravix, Grafix Xc |
| Paratek Pharmaceuticals, INC. | $309.63 | 2021-2025 | Nuzyra |
| Cardiovascular Systems INC. | $229.89 | 2020-2022 | |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Grt US Holding, INC. | $95.76 | 2021-2022 | |
| Angiodynamics, INC. | $77.98 | 2022 | |
| Forte Bio-Pharma LLC | $75.69 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $74.84 | 2023-2024 | Venclose Maven Catheter |
| Depuy Synthes Sales INC. | $74.35 | 2022-2025 | Minibunion |
| Organogenesis INC. | $74.27 | 2023 | Puraply |
| Globus Medical, INC. | $68.89 | 2025 | Senza |
| Alfasigma USA, INC. | $68.28 | 2021-2022 | |
| Cook Medical LLC | $57.50 | 2020 | |
| Ermi LLC | $57.34 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $54.91 | 2022-2024 | |
| Abbvie INC. | $50.60 | 2021-2024 | |
| Tactile Systems Technology INC | $47.05 | 2020-2025 | Flexitouch Plus, Nimbl |
| Horizon Therapeutics Plc | $41.81 | 2020-2022 | |
| Osiris Therapeutics INC. | $41.61 | 2019 | |
| Sandoz INC. | $40.77 | 2019 | |
| Orthofix Medical, INC. | $39.32 | 2019-2024 | Accelstim, Physio-Stim |
| Zimmer Biomet Holdings, INC. | $34.07 | 2020 | |
| Integra Lifesciences Corporation | $32.03 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $31.25 | 2024 | Dart-Fire |
| Vertex Pharmaceuticals Incorporated | $26.55 | 2025 | |
| Polynovo North America LLC | $26.34 | 2025 | Novosorb Btm |
| Baudax Bio INC. | $23.33 | 2022 | |
| Biotissue Holdings INC. | $21.76 | 2023 | |
| Medartis INC. | $21.57 | 2023 | Aptus |
| Wright Medical Technology, INC. | $20.58 | 2020 | |
| Mimedx Group, INC. | $20.24 | 2025 | |
| Bioventus LLC | $18.33 | 2019 | |
| Mayne Pharma Commercial LLC | $16.21 | 2021 | |
| Linvatec Corporation | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Lavian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.